Cancer Causes & Control

, Volume 22, Issue 3, pp 503–510

Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study

  • Shane Johnson
  • Woon-Puay Koh
  • Renwei Wang
  • Sugantha Govindarajan
  • Mimi C. Yu
  • Jian-Min Yuan
Original paper

DOI: 10.1007/s10552-010-9725-0

Cite this article as:
Johnson, S., Koh, WP., Wang, R. et al. Cancer Causes Control (2011) 22: 503. doi:10.1007/s10552-010-9725-0

Abstract

Background

Coffee consumption has been associated with reduced markers of hepatic cell damage, reduced risk of chronic liver disease, and cirrhosis across a variety of populations. Data on the association between coffee consumption and risk of hepatocellular carcinoma (HCC), especially in high-risk populations, are sparse.

Methods

This study examines the relationship between coffee and caffeine consumption, and the risk of developing HCC within the Singapore Chinese Health Study, a prospective cohort of 63,257 middle-aged and older Chinese men and women, a relatively high-risk population for HCC. Baseline data on coffee consumption and other dietary and lifestyle factors were collected through in-person interviews at enrollment between 1993 and 1998.

Results

As of 31 December 2006, 362 cohort participants had developed HCC. High levels of coffee or caffeine consumption were associated with reduced risk of HCC (p for trend < 0.05). Compared with non-drinkers of coffee, individuals who consumed three or more cups of coffee per day experienced a statistically significant 44% reduction in risk of HCC (hazard ratio 0.56, 95% confidence interval, 0.31–1.00, p = .049) after adjustment for potential confounders and tea consumption.

Conclusion

These data suggest that coffee consumption may reduce the risk of developing HCC in Chinese in Singapore.

Keywords

CoffeeCaffeineHCCHepatocellularLiver cancerGGT

Supplementary material

10552_2010_9725_MOESM1_ESM.doc (43 kb)
Supplementary material 1 (DOC 43 kb)
10552_2010_9725_MOESM2_ESM.doc (39 kb)
Supplementary material 2 (DOC 39 kb)
10552_2010_9725_MOESM3_ESM.doc (47 kb)
Supplementary material 3 (DOC 47 kb)

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Shane Johnson
    • 1
    • 2
  • Woon-Puay Koh
    • 3
  • Renwei Wang
    • 1
  • Sugantha Govindarajan
    • 4
  • Mimi C. Yu
    • 1
  • Jian-Min Yuan
    • 1
    • 2
  1. 1.The Masonic Cancer Center, MMC 806University of MinnesotaMinneapolisUSA
  2. 2.Division of Epidemiology and Community Health, School of Public HealthUniversity of MinnesotaMinneapolisUSA
  3. 3.Department of Epidemiology and Public Health, Yong Loo Lin School of MedicineNational University of SingaporeKent RidgeSingapore
  4. 4.Department of Clinical Pathology, Rancho Los Amigos National Rehabilitation Center, Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA